The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs. FTC’s report ...
The FTC's second interim staff report on consolidated pharmacy benefit managers (PBMs) found that the three largest of these ...
The report found top pharmacy benefit managers made more than $7.3 billion by marking up the prices of dozens of generic ...
The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...
They are also demanding of Apple something called interoperability, which absurdly requires Apple to hand over access to its private operating systems to its competitors and will require iPhones to ...